Norman D. Schwartz - 01 Nov 2023 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role: Chairman, President, and CEO, Director, 10%+ Owner
Signature: /s/ Norman Schwartz
Issuer symbol: BIO
Transactions as of: 01 Nov 2023
Net transactions value: -$4,817,860
Form type: 4
Filing time: 02 Nov 2023, 11:28:27 UTC
Previous filing: 06 Sep 2023
Next filing: 07 Dec 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BIO	Bio-Rad B Common Stock	Options Exercise	$4,193,000	+35,000	+10%	$119.80	380,300	01 Nov 2023	Direct
transaction	BIO	Bio-Rad B Common Stock	Tax liability	$7,000,266	-25,642	-6.7%	$273.00	354,658	01 Nov 2023	Direct
transaction	BIO	Bio-Rad B Common Stock	Options Exercise	$2,232,960	+16,000	+4.5%	$139.56	370,658	01 Nov 2023	Direct
transaction	BIO	Bio-Rad B Common Stock	Tax liability	$3,350,802	-12,274	-3.3%	$273.00	358,384	01 Nov 2023	Direct
transaction	BIO	Bio-Rad B Common Stock	Options Exercise	$2,389,800	+15,000	+4.2%	$159.32	373,384	01 Nov 2023	Direct
transaction	BIO	Bio-Rad B Common Stock	Tax liability	$3,282,552	-12,024	-3.2%	$273.00	361,360	01 Nov 2023	Direct
holding	BIO	Bio-Rad B Common Stock						12,900	01 Nov 2023	By Spouse	F1
holding	BIO	Bio-Rad B Common Stock						4,060,054	01 Nov 2023	By Blue Raven Partners, L.P.	F2
holding	BIO	Bio-Rad A Common Stock						432,920	01 Nov 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BIO	Non-Qualified Stock Option (right to buy)	Options Exercise	$0	-35,000	-100%	$0.000000^*	0	01 Nov 2023	Bio-Rad B Common Stock	35,000	$119.80	Direct	F3
transaction	BIO	Non-Qualified Stock Option (right to buy)	Options Exercise	$0	-16,000	-100%	$0.000000^*	0	01 Nov 2023	Bio-Rad B Common Stock	16,000	$139.56	Direct	F4
transaction	BIO	Non-Qualified Stock Option (right to buy)	Options Exercise	$0	-15,000	-100%	$0.000000^*	0	01 Nov 2023	Bio-Rad B Common Stock	15,000	$159.32	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reporting person disclaims beneficial ownership of these shares.
F2	The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F3	The option, representing a right to purchase a total of 35,000 shares, became exercisable in five equal annual installments beginning on September 10, 2015, which was the first anniversary of the date on which the option was granted.
F4	The option, representing a right to purchase a total of 16,000 shares, became exercisable in five equal annual installments beginning on September 11, 2016, which was the first anniversary of the date on which the option was granted.
F5	The option, representing a right to purchase a total of 15,000 shares, became exercisable in five equal annual installments beginning on September 7, 2017, which was the first anniversary of the date on which the option was granted.